Article Versions Notes

Badacz R, Kleczyński P, Legutko J, Żmudka K, Gacoń J, Przewłocki T, Kabłak-Ziembicka A. Expression of miR-1-3p, miR-16-5p and miR-122-5p as Possible Risk Factors of Secondary Cardiovascular Events. Biomedicines. 2021; 9(8):1055. https://doi.org/10.3390/biomedicines9081055

Badacz, Rafał, Paweł Kleczyński, Jacek Legutko, Krzysztof Żmudka, Jacek Gacoń, Tadeusz Przewłocki, and Anna Kabłak-Ziembicka. 2021. "Expression of miR-1-3p, miR-16-5p and miR-122-5p as Possible Risk Factors of Secondary Cardiovascular Events" Biomedicines 9, no. 8: 1055. https://doi.org/10.3390/biomedicines9081055

Badacz, R., Kleczyński, P., Legutko, J., Żmudka, K., Gacoń, J., Przewłocki, T., & Kabłak-Ziembicka, A. (2021). Expression of miR-1-3p, miR-16-5p and miR-122-5p as Possible Risk Factors of Secondary Cardiovascular Events. Biomedicines, 9(8), 1055. https://doi.org/10.3390/biomedicines9081055